Kissei Pharmaceutical Co (JP:4547) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Kissei Pharmaceutical Co., Ltd. has announced its decision to acquire up to 1,400,000 of its own shares, representing 3.17% of the total issued shares, as part of a strategy to enhance capital efficiency and shareholder returns. The transaction will be conducted through the Tokyo Stock Exchange’s off-auction trading system, with a maximum acquisition cost set at 5.29 billion yen. The company also plans to cancel all treasury shares acquired during this process by November 29, 2024.
For further insights into JP:4547 stock, check out TipRanks’ Stock Analysis page.